Papillary Type 2 Renal Cell Carcinoma in a Young Patient - Renal and Urology News

Papillary Type 2 Renal Cell Carcinoma in a Young Patient

Slideshow

  • Computed tomography scans demonstrating 5 cm left and 1 cm right enhancing renal masses in a young patient who proved to harbor type 2 papillary renal cell carcinoma upon resection.

    Precon

    Computed tomography scans demonstrating 5 cm left and 1 cm right enhancing renal masses in a young patient who proved to harbor type 2 papillary renal cell carcinoma upon resection.

  • Computed tomography scans demonstrating 5 cm left and 1 cm right enhancing renal masses in a young patient who proved to harbor type 2 papillary renal cell carcinoma upon resection.

    Postcon

    Computed tomography scans demonstrating 5 cm left and 1 cm right enhancing renal masses in a young patient who proved to harbor type 2 papillary renal cell carcinoma upon resection.

  • Computed tomography scans demonstrating 5 cm left and 1 cm right enhancing renal masses in a young patient who proved to harbor type 2 papillary renal cell carcinoma upon resection.

    Coronal

    Computed tomography scans demonstrating 5 cm left and 1 cm right enhancing renal masses in a young patient who proved to harbor type 2 papillary renal cell carcinoma upon resection.

A 43-year-old man presented with bilateral renal masses. He underwent a left partial nephrectomy, with pathology revealing type 2 papillary renal cell carcinoma. He reported that his twin sister underwent hysterectomy approximately 10 years previously for refractory uterine bleeding.

This case was prepared by Alexander Kutikov, MD, of Fox Chase Cancer Center in Philadelphia.  REFERENCEMenko FH, Maher ER, Schmidt S, et al. Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC): Renal Cancer Risk, Surveillance and Treatment. Fam Cancer 2014;13:637-644. Answer: DYoung patients with type...

Submit your diagnosis to see full explanation.

This case was prepared by Alexander Kutikov, MD, of Fox Chase Cancer Center in Philadelphia. 

 

REFERENCE

Menko FH, Maher ER, Schmidt S, et al. Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC): Renal Cancer Risk, Surveillance and Treatment. Fam Cancer 2014;13:637-644.

 

Answer: D

Young patients with type 2 papillary renal cell carcinoma should be screened for hereditary leiomyomatosis and renal cell cancer syndrome, autosomal dominant conditions associated with fumarate hydratase (FH) mutation. Approximately 15% of patients with FH mutation will develop renal malignancy over their life time. Given the aggressive biological behavior of type 2 papillary lesions, unlike in cases of other hereditary RCC syndromes, resection of the right renal mass should not be delayed in patients with bilateral tumors.

Next hm-slideshow in Clinical Quiz